FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079138856> ?p ?o ?g. }

• W2079138856 endingPage "246" @default.
• W2079138856 startingPage "239" @default.
• W2079138856 abstract "Labeling derivatives of dihydrotetrabenazine (DTBZ) with F-18 (T(1/2)=110 min) instead of C-11 (T(1/2)=20 min) would improve their utility and availability for imaging vesicular monoamine transporters (VMAT2) in clinical settings. The successful synthesis, reported previously, of two novel 9-fluoroalkyl(+/-)-DTBZ ligands prompted us to study the optically resolved active ligand 9-fluoropropyl-(+)-DTBZ (FP-(+)-DTBZ), which may have more promising characteristics. The inhibition constant (K(i)) estimated for FP-(+)-DTBZ (using [(3)H](+/-)-DTBZ as the labeled ligand in rat striatal homogenates) showed a lower value as compared to the racemic FP-(+/-)-DTBZ (0.10+/-0.01 vs 0.19+/-0.04 nM). The inactive isomer, FP-(-)-DTBZ, displayed a much lower binding affinity with a K(i) value >3000 nM. Biodistribution studies in mice after an iv injection of [(18)F]FP-(+)-DTBZ exhibited a ratio of striatum (ST, target) to cerebellum (CB, background) of 4.51 at 30 min postinjection, which is a higher value than previously obtained with the racemic ligand [(18)F]FP-(+/-)-DTBZ (ST/CB=2.95). Brain extraction at 30 min after the tracer injection in mice showed that >95% of the radioactivity corresponded to the parent, nonmetabolized, compound remaining in the ST, suggesting that the tracer has an excellent in vivo stability. Furthermore, localization of the tracer in the brain examined with ex vivo autoradiography displayed a typical distribution pattern consistent with VMAT2 sites. The highest labeling was observed in monoaminergic neuron regions (caudate putamen, olfactory tubercle, nucleus accumbens, substantia nigra, dorsal raphe and locus coerules). We also tested the selective labeling of this tracer at the dopamine neurons in unilateral-lesioned mice (treated with 6-hydroxydopamine). When [(18)F]FP-(+)-DTBZ and [(125)I]IPT ((N-(3'-iodopropen-2'-yl)-2-beta-carbomethoxy-3-beta-(4-chlorophenyl)tropane, a selective marker for dopamine transporters (DATs) in dopaminergic neurons) were simultaneously injected into lesioned mice, we observed an excellent correlation (r=0.95) for these tracers. From these findings, we conclude that [(18)F]FP-(+)-DTBZ is a sensitive and selective tracer for VMAT2 binding sites and it may be useful for in vivo evaluation of diseases relating to changes of monoamine neuronal integrity." @default.
• W2079138856 created "2016-06-24" @default.
• W2079138856 creator A5018946573 @default.
• W2079138856 creator A5046436153 @default.
• W2079138856 creator A5047749745 @default.
• W2079138856 creator A5055131918 @default.
• W2079138856 creator A5057127088 @default.
• W2079138856 creator A5082627212 @default.
• W2079138856 date "2007-04-01" @default.
• W2079138856 modified "2023-10-07" @default.
• W2079138856 title "Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters" @default.
• W2079138856 cites W1766910547 @default.
• W2079138856 cites W1943795612 @default.
• W2079138856 cites W1975827069 @default.
• W2079138856 cites W1982077726 @default.
• W2079138856 cites W1992474618 @default.
• W2079138856 cites W2009777989 @default.
• W2079138856 cites W2019685130 @default.
• W2079138856 cites W2022516265 @default.
• W2079138856 cites W2027274005 @default.
• W2079138856 cites W2035943055 @default.
• W2079138856 cites W2045716051 @default.
• W2079138856 cites W2060361404 @default.
• W2079138856 cites W2077955240 @default.
• W2079138856 cites W2078245222 @default.
• W2079138856 cites W2078421572 @default.
• W2079138856 cites W2085840951 @default.
• W2079138856 cites W2086835149 @default.
• W2079138856 cites W2092935447 @default.
• W2079138856 cites W2094043381 @default.
• W2079138856 cites W2099504034 @default.
• W2079138856 cites W2104237054 @default.
• W2079138856 cites W2105973905 @default.
• W2079138856 cites W2110886758 @default.
• W2079138856 cites W2115524468 @default.
• W2079138856 cites W2150772125 @default.
• W2079138856 cites W2151128435 @default.
• W2079138856 cites W2158278592 @default.
• W2079138856 cites W2418453678 @default.
• W2079138856 cites W2421586028 @default.
• W2079138856 cites W4238846792 @default.
• W2079138856 doi "https://doi.org/10.1016/j.nucmedbio.2006.12.005" @default.
• W2079138856 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1919419" @default.
• W2079138856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17383573" @default.
• W2079138856 hasPublicationYear "2007" @default.
• W2079138856 type Work @default.
• W2079138856 sameAs 2079138856 @default.
• W2079138856 citedByCount "72" @default.
• W2079138856 countsByYear W20791388562012 @default.
• W2079138856 countsByYear W20791388562013 @default.
• W2079138856 countsByYear W20791388562014 @default.
• W2079138856 countsByYear W20791388562015 @default.
• W2079138856 countsByYear W20791388562016 @default.
• W2079138856 countsByYear W20791388562017 @default.
• W2079138856 countsByYear W20791388562018 @default.
• W2079138856 countsByYear W20791388562019 @default.
• W2079138856 countsByYear W20791388562020 @default.
• W2079138856 countsByYear W20791388562021 @default.
• W2079138856 countsByYear W20791388562022 @default.
• W2079138856 countsByYear W20791388562023 @default.
• W2079138856 crossrefType "journal-article" @default.
• W2079138856 hasAuthorship W2079138856A5018946573 @default.
• W2079138856 hasAuthorship W2079138856A5046436153 @default.
• W2079138856 hasAuthorship W2079138856A5047749745 @default.
• W2079138856 hasAuthorship W2079138856A5055131918 @default.
• W2079138856 hasAuthorship W2079138856A5057127088 @default.
• W2079138856 hasAuthorship W2079138856A5082627212 @default.
• W2079138856 hasBestOaLocation W20791388562 @default.
• W2079138856 hasConcept C107824862 @default.
• W2079138856 hasConcept C116569031 @default.
• W2079138856 hasConcept C126322002 @default.
• W2079138856 hasConcept C134018914 @default.
• W2079138856 hasConcept C170493617 @default.
• W2079138856 hasConcept C185592680 @default.
• W2079138856 hasConcept C187714386 @default.
• W2079138856 hasConcept C202751555 @default.
• W2079138856 hasConcept C2775864247 @default.
• W2079138856 hasConcept C2776284327 @default.
• W2079138856 hasConcept C2776291748 @default.
• W2079138856 hasConcept C2777807558 @default.
• W2079138856 hasConcept C2780062018 @default.
• W2079138856 hasConcept C513476851 @default.
• W2079138856 hasConcept C55493867 @default.
• W2079138856 hasConcept C67847695 @default.
• W2079138856 hasConcept C71924100 @default.
• W2079138856 hasConcept C86803240 @default.
• W2079138856 hasConceptScore W2079138856C107824862 @default.
• W2079138856 hasConceptScore W2079138856C116569031 @default.
• W2079138856 hasConceptScore W2079138856C126322002 @default.
• W2079138856 hasConceptScore W2079138856C134018914 @default.
• W2079138856 hasConceptScore W2079138856C170493617 @default.
• W2079138856 hasConceptScore W2079138856C185592680 @default.
• W2079138856 hasConceptScore W2079138856C187714386 @default.
• W2079138856 hasConceptScore W2079138856C202751555 @default.
• W2079138856 hasConceptScore W2079138856C2775864247 @default.
• W2079138856 hasConceptScore W2079138856C2776284327 @default.
• W2079138856 hasConceptScore W2079138856C2776291748 @default.
• W2079138856 hasConceptScore W2079138856C2777807558 @default.

• next